Gregory D. Busse

651 citations
33 papers · 509 · h-index 14

Impact in

Papers in

Gregory D. Busse

33 papers receiving 491 citations

Peers

Gregory D. Busse
Comparison fields: 5 of 54
  • Psychiatry and Mental health 277
  • Cellular and Molecular Neuroscience 147
  • Behavioral Neuroscience 27
  • Cognitive Neuroscience 125
  • Toxicology 15
Replace Kerri A. Pierz with:
Kerri A. Pierz United States
Susan Simmons-Alling United States
P. Danjou France
Caroline A. Arout United States
Gad Klein United States
R. Liljequist Finland
E. Pinto Belgium
Frank Enning Germany
Diana Limoncelli United States
Charles Merideth United States
Gregory D. Busse relative to Kerri A. Pierz United States Kerri A. Pierz's profile →
Citations per field
00.5×5.6×
Kerri A. Pierz · 1×
Citations per year

Countries citing papers authored by Gregory D. Busse

Since Specialization
Citations

This map shows the geographic impact of Gregory D. Busse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory D. Busse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory D. Busse more than expected).

Fields of papers citing papers by Gregory D. Busse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory D. Busse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory D. Busse. The network helps show where Gregory D. Busse may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory D. Busse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory D. Busse Line = papers co-authored together Gregory D. Busse links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202066
2 202140
3 202135
4
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHD.
202130
5 200530
6 200327
7 200726
8 202123
9 200521
10 200620
11 200214
12 200814
13 202014
14 202113
15 202113
16 200313
17 202213
18 202112
19 197012
20 200511

About Gregory D. Busse

Gregory D. Busse is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience, Cognitive Neuroscience, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 33 papers that have together received 509 indexed citations. Recurring topics across this work include Attention Deficit Hyperactivity Disorder (15 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Memory and Neural Mechanisms (4 papers), Bipolar Disorder and Treatment (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Forensic Toxicology and Drug Analysis (2 papers), Cannabis and Cannabinoid Research (2 papers) and Behavioral and Psychological Studies (2 papers). The work is most often cited by research in Psychiatry and Mental health (277 citations), Cellular and Molecular Neuroscience (147 citations), Behavioral Neuroscience (27 citations), Cognitive Neuroscience (125 citations) and Toxicology (15 citations). Gregory D. Busse has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Anthony L. Riley, Azmi Nasser, Joseph T. Hull, Tesfaye Liranso, Stefan Schwabe, Fatima Chowdhry, Zare Melyan, Robert L. Findling, Andrew J. Cutler and Jonathan Rubin. Their work appears in journals such as Pharmacology Biochemistry and Behavior, Journal of the American Academy of Child & Adolescent Psychiatry, Psychiatry Research, Progress in Neuro-Psychopharmacology and Biological Psychiatry and Clinical Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact